Spedizione gratuita per ordini superiori a 69,99 euro.

Controllare lo stato dell'ordine

Entra a far parte di una comunità di amanti dei libri di tutto il mondo e ottieni numerosi vantaggi. Crea un account gratuito

Spedizione gratuita con Packeta per un prezzo superiore a 69.99 €

Bartolini 4.49 € Punto Poste 5.49 € Punto Poste 5.49 € Punto Bartolini 3.49 € DHL 6.99 € GLS 5.99 €

Contatto

Come acquistare

Aiuto

Il mio account

▸ Vuoto :-(

Spedizione gratuita per ordini superiori a 69,99 euro.

Anticancer Drug Development Guide

Name: Anticancer Drug Development Guide
Brand: Springer-Verlag New York Inc.
SKU: 02269490
Price: 107.29 EUR
Availability: InStock
Author: Beverly A. Teicher
ISBN: 9781461581543

Preclinical Screening, Clinical Trials, and Approval

Beverly A. Teicher

Lingua

Inglese

Libro In brossura

Codice Libristo: 02269490

Casa editrice Springer-Verlag New York Inc., giugno 2013

Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia... Descrizione completa

Codice Libristo: 02269490

263 b

107.29 €

Magazzino esterno Inviamo tra 5-8 giorni

30 giorni per il reso

I clienti hanno acquistato anche

Übungsfragen Biologie Hans B. Strack

In brossura

55.29 €

Follies of Essex Gwyn Headley Libro elettronico

Adobe ePub DRM

4.29 €

Un experiment de crítica literaria C S Lewis

In brossura

20.29 €

Divoké prase

Giocattolo

7.59 €

Válka a její strašlivá láska James Hillman

Foglio

13.39 €

Hledání zázračného P.D. Uspenskij

In brossura

14.19 €

Gemeinsam Singen Wir Tiroler Lieder Sonnalp Trio

CD audio

16.39 €

Demokratie heute - Ausgabe 2015 für Niedersachsen, m. 1 Buch, m. 1 Online-Zugang Dieter Deiseroth

Rigido

32.29 €

Basische Kost Doris Wroblewski

In brossura

13.79 €

Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval. They focus on using preclinical in vivo and in vitro methods to identify molecules of interest, detailing the targets and criteria for success in each type of testing and defining the value of the information obtained from the various tests. They also define each stage of clinical testing, explain the criteria for success, and outline the requirements for FDA approval. A companion volume by the same editor (Cancer Therapeutics: Experimental and Clinical Agents) reviews existing anticancer drugs and potential anticancer therapies. These two volumes in the Cancer Drug Discovery and Development series reveal how and why molecules become anticancer drugs and thus offer a blueprint for the present and the future of the field.